Health
FDA Approves Moderna Flu Shot
The FDA’s independent vaccine advisors unanimously approved Moderna’s mFlusiva flu shot for people aged 50 to 64 and those over 65. This decision comes as healthcare providers seek new options to combat seasonal influenza.
Coverage timeline — 2 articles
The Hill
Presented by Philip Morris International {beacon} Technology Technology PRESENTED BY The Big Story GOP embraces speculation about China’s role in data center backlash Republicans are embracing allegations that data center opposition in the U.S. is being fueled by foreign actors, raising questions
2026-06-18 23:20 UTC
The Hill
Presented by Planned Parenthood {beacon} Healthcare Health Care PRESENTED BY The Big Story FDA panel gives nod to Moderna flu shot The FDA’s independent vaccine advisors voted unanimously 9-0 that the benefits outweigh the risks for Moderna’s mFlusiva shot in people ages 50 to 64 as well as 65
2026-06-18 23:37 UTC